AIS's Health Business Daily is a daily email newsletter with strategic business stories written by experienced AIS Health reporters, as well as other information of interest to health care business leaders — including news from the nation’s leading health insurers, developments from the federal and state governments that impact the health care industry, and exclusive datapoints from Subscribe now to get an issue delivered to your inbox every morning!
October 24, 2017
Hot Topic
Health insurers face unprecedented cost and complexity in deciding whether and how to cover new gene therapies coming to market. Here’s a look at recent developments.
If the FDA follows an advisory committee’s lead, the agency will approve a gene therapy that treats a rare form of blindness by early next year....
Barely three months after the FDA approved Keytruda (pembrolizumab) as the first tissue- and site-agnostic cancer drug, the agency hit another milestone with the approval of the first chimeric antigen receptor T cell (CAR-T) therapy....
Value-based contracts are one way to counter the ever-increasing spending on specialty drugs...
Quest Diagnostics

Today's AIS Health Datapoint
3,309,732 ... is the current enrollment for WellCare Health Plans, Inc., as a result of its acquisitions of Phoenix Health Plan and Universal American Corp. This figure represents an increase of more than 330,000 lives since AIS Health initially published its Directory of Health Plans in May.

Quote of the Day
“Every [Blue Cross and Blue Shield] plan I’ve met with is very positive and optimistic” about large group sales and renewals, with “reasonable” rate increases around 3% to 5%. “Anytime you can get that on a consecutive basis is fantastic. I’m seeing good, strong renewals.”
— Ashraf Shehata, principal and health care leader at KPMG LLP, tells AIS Health that Blues plans have had good success renewing large groups, and there’s been relatively little movement between carriers.

The Featured Story of the day may be accessed on the day it is transmitted without logging in to Thereafter, you may need to log in to access the Featured Story. If you haven’t yet registered on, please take a minute to create a free account now and get free access to thousands of articles, blogs and much more.

Questions or suggestions about the content in AIS's HEALTH BUSINESS DAILY should be directed to Executive Editor Jill Brown at

AIS's HEALTH BUSINESS DAILY is copyrighted and protected by federal law. The re-use of its content is restricted (see below). However, you are permitted to forward this email to as many of your friends and colleagues as you wish, or better yet have them sign up for their own copy at atlantic_subscription.cfm

Copyright © 2017 Managed Markets Insight & Technology, LLC. All rights reserved. It is not permissible to include all or any portion of this content on any Web site, intranet or electronic network or in any print publication, without AIS's written permission in advance. Permission requests should be directed to